drugID;nameEMBL2016;drugSynonyms;target;targetFamily;pathway;addTarget;nameCPS1000;nameIC50;nameTri12;nameSMART;nameSZ;Class
156441;Tozasertib;MK-045, MK-0457,VX-680;AURKA, AURKB;AURKA/B;Cell cycle;AURKB, AURKC, FLT3, ABL1;Tozasertib;NA;NA;;;Kinase inhibitor
166750;Necrostatin-1;NA;RIP1;RIP1;Necroptosis;;NA;NA;NA;;;Apoptotic modulator
190001;Selumetinib;AZD6244, ARRY886;MAP2K1, MAPK3, MAPK1;MEK/ERK;MAPK;;NA;selumetinib;Selumetinib;;;Kinase inhibitor
190002;AZD7762;NA;CHEK1, CHEK2;CHEK1/2;DDR;ATR;NA;AZD7762;NA;;;Kinase inhibitor
190003;Enzastaurin;LY317615;PRKCB;PRKCB;PKC;PRKCA, PRKCG, PRKCE;NA;enzastaurin;NA;;;Kinase inhibitor
190004;Fludarabine;NA;POLA1, DNA;DNA;Chemotherapy;RRM1,DCK;Fludarabine;fludarabine;Fludarabine;;;Conventional Chemo
190007;SNS-032;BMS-387032;CDK2, CDK7, CDK9;CDK;Cell cycle;GSK3A, CDK5;NA;SNS-032;NA;;;Kinase inhibitor
190008;Vorinostat;SAHA, MK0683;HDAC1, HDAC3;HDAC1/3;Histone deacetylase;HDAC2, HDAC6, HDAC8;NA;vorinostat;NA;;;Differentiating /Epigenetic modifier
190191;Chaetoglobosin A;NA;Unknown;Fungal toxin;Cytoskeleton;;NA;chaetoglobosin A;Chaetoglobosin A;;;Other
190193;THZ1;THZ-1;CDK7;CDK7;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190195;Daunorubicin;Daunomycin;DNA, TOP2A, TOP2B;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
190201;BMS-509744;KIN001-127;ITK;ITK;ITK;;BMS-509744;NA;NA;;;Kinase inhibitor
190202;JAK3 Inhibitor I;WHI-P131;JAK3;JAK3;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190203;Kifunensine;NA;MAN2A1, MAN1B1;Mannosidase;Protein glycosylation;MSDC;NA;NA;NA;;;Other
190204;MK-2 Inhibitor III;NA;MAPKAPK2;MAPKAPK2;MAPK;MAPKAPK3, MAPKAPK5;NA;NA;NA;;;Kinase inhibitor
190205;NOX1 Inhibitor;ML171;NOX1;NOX1;Metabolism;;NA;NA;NA;;;Metabolic modifier
190206;Rigosertib;ON-01910;PLK1;PLK1;PLK;PLK2;NA;rigosertib;NA;;;Kinase inhibitor
190207;PKM2 Activator II;PKM2 Activator II, diarylsulfonamide;PKM;PKM;Metabolism;;NA;NA;NA;;;Metabolic modifier
190208;Wee1 Inhibitor;Wee1_Inhibitor;WEE1, CHEK1;WEE1;Cell cycle;;NA;NA;Wee1_Inhibitor;;;Kinase inhibitor
190209;QS11 Hydrate;Wnt Synergist QS11;ARFGAP1, ASAP1;ARFGAP1;Wnt;;NA;NA;NA;;;Other
190210;Navitoclax;Abt-263;BCL2, BCL2L1, BCL2L2;BCL2;Apoptosis;BAD;NA;navitoclax;NA;;;Apoptotic modulator
190211;Linifanib;ABT-869;KDR, CSF1R, FLT1, FLT3;VEGFR/PDGFR;Angiogenesis;KIT, PDGFRB, TEK, FLT4;NA;NA;NA;;;Kinase inhibitor
190212;Veliparib;ABT-888;PARP1, PARP2;PARP1/2;DDR;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190213;Bleomycin;Bleomycin Sulfate;LIG1, LIG3, DNA;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
190214;Saracatinib;AZD-0530, KIN001-045, AZD0530;SRC, LCK, YES1, LYN, FYN;SRC;BCR;EGFR(L861Q), EGFR(L858R), EGFR, FGR, ABL2, KIT, EPHA2;NA;saracatinib;NA;;;Kinase inhibitor
190215;BEZ235;NVP-BEZ23;PIK3CA, PIK3CG, PIK3CG, MTOR;PI3K/MTOR;PI3K/AKT/mTOR;ATR;NA;NA;NA;;;Kinase inhibitor
190216;Nintedanib;BIBF 1120, BIBF1120, Vargatef;FLT1, KDR, FLT4, FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB;VEGFR/FGFR/PDGFR;Angiogenesis;FLT3,LCK,LYN,SRC;NA;NA;NA;;;Kinase inhibitor
190217;Afatinib;Tovok, BIBW2992;EGFR, ERBB2;EGFR/ERBB2;EGFR;EGFR, ERBB2,ERBB4;Afatinib;afatinib;NA;;;Kinase inhibitor
190218;BMS-536924;KIN001-126;IGF1R, INSR;IGF1R;IGF;PTK2, MAP2K1,LCK;NA;NA;NA;;;Kinase inhibitor
190221;Cediranib;AZD-2171, AZD2171;KDR;VEGFR2;Angiogenesis;KIT, FLT4, FLT1, PDGFRB, FGFR1, PDGFRA;NA;NA;NA;;;Kinase inhibitor
190226;Lenalidomide;CC-5013;TNFSF11;TNF;TNF/NFKB;CRBN,CDH5,PTGS2;NA;NA;Lenalidomide;;;Immunomodulatory
190228;Motesanib;AMG-706, Motesanib Diphosphate;FLT1, KDR, FLT4, KIT;VEGFR2;Angiogenesis;PDGFRB, RET;NA;NA;NA;;;Kinase inhibitor
190229;NVP-AEW541;AEW541;IGF1R;IGF1R;IGF;FLT3, TEK, FLT1, ERBB4, PDGFRB, KDR, SRC, FLT4, KIT, MET, ERBB2, FGFR1, PDPK1, ERBB1;NA;NA;NA;;;Kinase inhibitor
190230;PD0325901;NA;MAP2K1, MAP2K2;MEK1/2;MAPK;;NA;NA;NA;;;Kinase inhibitor
190231;PI-103;NA;PIK3CA, PIK3CB, PIK3CD;PI3K;PI3K/AKT/mTOR;PIK3CG, PRKDC, MTOR;NA;NA;NA;;;Kinase inhibitor
190232;Rapamycin;AY-22989, Sirolimus, WY-090217;MTOR;MTOR;PI3K/AKT/mTOR;FKBP1A, FGF2;Rapamycin;NA;NA;;;Rapalog
190234;Temsirolimus;CCI-779, NSC 683864;MTOR;MTOR;PI3K/AKT/mTOR;;NA;NA;NA;;;Rapalog
190235;Vandetanib;Zactima, ZD6474;KDR;VEGFR2;Angiogenesis;PTK6, ANGPT1, RET,FLT4, EGFR;NA;NA;NA;;;Kinase inhibitor
190237;Elesclomol;STA-4783;HSPA1A, HSPA1B;HSP70;Stress response;;NA;NA;NA;;;HSP inhibitor
190240;Obatoclax;GX15-070;BCL2, BCL2L1, MCL1;BCL2;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190241;Olaparib;KU-0059436, AZD2281;PARP1, PARP2;PARP1/2;DDR;PARP3;Olaparib;NA;NA;;;Differentiating /Epigenetic modifier
190242;Masitinib;AB-1010, AB1010;KIT, PDGFRA, PDGFRB;KIT;KIT;ABL1, CSF1R;NA;NA;NA;;;Kinase inhibitor
190243;Pictilisib;GDC0941;PIK3CA, PIK3CD;PI3K;PI3K/AKT/mTOR;PIK3CB, PIK3CG, MTOR;NA;NA;NA;;;Kinase inhibitor
190245;Luminespib;AUY922, VER-52296, NVP-AUY922;HSP90AB1, HSP90AA1;HSP90;Stress response;;NA;NA;NA;;;HSP inhibitor
190246;PHA-665752;NA;MET;MEK;HGF;RON, KDR;NA;NA;NA;;;Kinase inhibitor
190247;ZSTK474;NA;PIK3CD;PI3K;PI3K/AKT/mTOR;PIK3CA, PIK3CG, PIK3CB;NA;NA;NA;;;Kinase inhibitor
190248;SB216763;SB 216763;GSK3A, GSK3B;GSK3A/B;GSK3;;NA;NA;NA;;;Kinase inhibitor
190249;SB203580;SB 203580;MAPK14;p38;MAPK;MAPK12, MAPK13, AKT1;SB-203580;NA;SB 203580;;;Kinase inhibitor
190250;MK-2206;MK-2206 dihydrochloride;AKT1, ATK2, ATK3;AKT;PI3K/AKT/mTOR;;MK-2206;MK-2206;MK-2206;;;Kinase inhibitor
190252;Brivanib;BMS-540215;KDR;VEGFR2;Angiogenesis;FLT1, FGFR1;NA;NA;NA;;;Kinase inhibitor
190254;Iniparib;BSI-201;PARP1;PARP1;DDR;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190255;KU-55933;NA;ATM;ATM;DDR;;KU-55933;NA;NA;;;Kinase inhibitor
190256;Dacinostat;LAQ824, NVP-LAQ824;HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, HDAC10, HDAC11;pan-HDAC;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190257;Rucaparib;PF-01367338, AG-014699;PARP1, PARP2, PARP3;PARP1/2/3;DDR;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190259;Vatalanib;PTK-787;KDR;VEGFR2;Angiogenesis;FLT1, PDGFRB, FLT4;NA;NA;NA;;;Kinase inhibitor
190261;GDC-0879;NA;BRAF;BRAF;MAPK;RAF1;NA;NA;NA;;;Kinase inhibitor
190262;OSU-03012;AR-12;PDPK1;PDPK1;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190263;TAE684;KIN001-017, NVP-TAE684;ALK;ALK;ALK;;NA;TAE684;NA;;;Kinase inhibitor
190264;BI-2536;KIN001-124, BI 2536;PLK1;PLK1;PLK;PLK2,PLK3;NA;NA;NA;;;Kinase inhibitor
190265;Foretinib;EXEL-2880, GSK1363089;MET, KDR;MET;HGF;HGF,TEK, FLT4, RON, FLT3, PDGFRA, KIT, FLT1, PDGFRB;Foretinib;NA;NA;;;Kinase inhibitor
190266;SGX-523;NA;MET;MET;HGF;;NA;SGX-523;NA;;;Kinase inhibitor
190267;GSK690693;937174-76-0;AKT1, AKT2, AKT3;AKT;PI3K/AKT/mTOR;PRKCH, PRKCQ, PRIKX, PRKCD, PRKCB, PRKCE, PRKACA, PRKG1;NA;NA;NA;;;Kinase inhibitor
190268;Odanacatib;MK-0822, MK 0822;CTSK;CTSK;Cystein protease;;NA;NA;NA;;;Protease/Proteosome inhibitor
190269;Palbociclib;PD-0332991;CDK4, CDK6;CDK4/6;Cell cycle;;Palbociclib;NA;PD-0332991;;;Kinase inhibitor
190270;Cabozantinib;XL184, BMS-907351;KDR;VEGFR2;Angiogenesis;MET, RET, KIT, FLT1, FLT3, FLT4, TEK, AXL;NA;NA;NA;;;Kinase inhibitor
190272;TW-37;TW 37;BCL2, BCL2L1, MCL1;BCL2;Apoptosis;;TW-37;NA;NA;;;Apoptotic modulator
190273;BMS-754807;NA;IGF1R, INSR;IGF1R;IGF;MET, AURKA, AURKB, NTRK1A, NTRK1B, MST1R;NA;NA;NA;;;Kinase inhibitor
190274;Sepantronium Bromide;YM155;BIRC5;BIRC5;Apoptosis;;NA;YM155;NA;;;Apoptotic modulator
190275;AT9283;NA;JAK2, JAK3, AURKA;JAK2/3;JAK/STAT;AURKB,ABL1, FGFR2, FLT4, MERTK, RET, RPS6KA3, RPS6KA2, TYK2, YES1;NA;NA;NA;;;Kinase inhibitor
190276;17-AAG;Tanespimycin;HSP90AA1, HSP90AB1;HSP90;Stress response;;NA;NA;NA;;;HSP inhibitor
190278;Barasertib;AZD-1152HQPA, AZD1152-HQPA;AURKB;AURKB;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190279;Docetaxel;RP-56976, Taxotere;TUBB1;TUBB;Chemotherapy;BCL2, MAP2, MAP4, MAPT, NR1I2;NA;NA;NA;;;Conventional Chemo
190280;PLX-4720;NA;BRAF(V600E), RAF1(Y340D/Y341D);BRAF(V600E);MAPK;BRAF, PTK6;NA;NA;NA;;;Kinase inhibitor
190282;NSC-74859;S3I-201, NSC 74859;STAT3;STAT3;JAK/STAT;;NA;NSC 74859;NA;;;Kinase inhibitor
190283;Onalespib;AT13387;HSP90AA1, HSP90AB1;HSP90;Stress response;;Onalespib;AT13387;Onalespib;;;HSP inhibitor
190284;Lenvatinib;E7080;KDR, FLT4;VEGFR2/3;Angiogenesis;FLT1, PDGFRB, PDGFRA, FGFR1, KIT;NA;NA;NA;;;Kinase inhibitor
190285;Cisplatin;cis-Diammineplatinum(II) dichloride;DNA;DNA;Chemotherapy;;Cisplatin;NA;NA;;;Conventional Chemo
190286;TGX-221;NA;PIK3CB;PI3K;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190287;Serdemetan;JNJ-26854165, JNJ 26854165;MDM2, HDM2;MDM2;DDR;;NA;NA;NA;;;Apoptotic modulator
190288;XAV-939;NA;TNKS, TNKS2;TNKS;Wnt;;NA;NA;NA;;;Other
190289;BIBR1532;BIBR-1532;TERT;Telomerase;Telomerase;;NA;NA;NA;;;Other
190292;PIK-75;NA;PIK3CA, PRKDC;PI3K;PI3K/AKT/mTOR;PIK3CG, PIK3CD;NA;NA;NA;;;Kinase inhibitor
190293;Doxorubicin;Doxil, Rubex, Adriamycin, Doxorubicine;TOP2A, TOP2B;TOP2;Chemotherapy;;Doxorubicine;doxorubicine;Doxorubicin;;;Conventional Chemo
190296;Bendamustine;SDX-105;DNA;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
190298;Etoposide;VP-16;TOP2A, TOP2B;TOP2;Chemotherapy;CYP3A4;NA;NA;NA;;;Conventional Chemo
190299;Ku-0063794;NA;MTOR;MTOR;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190300;Flavopiridol;Alvocidib;CDK1, CDK2, CDK4, CDK5, CDK6, CDK9;CDK;Cell cycle;PYGM, EGFR, PYGB, PYGL, ABCG2;NA;NA;NA;;;Kinase inhibitor
190301;Avagacestat;BMS-708163;APP;APP;Notch;;NA;NA;NA;;;Other
190302;CHIR-99021;CT 99021, CT99021;GSK3A, GSK3B;GSK3A/B;GSK3;;NA;NA;CHIR-99021;;;Kinase inhibitor
190303;PD173074;PD-173074;FGFR1;FGFR1;FGFR;KDR;NA;NA;NA;;;Kinase inhibitor
190305;BX-795;BX 795;PDPK1;PDPK1;PI3K/AKT/mTOR;KIT, CDK2, CHEK1;NA;NA;NA;;;Kinase inhibitor
190306;BX-912;NA;PDPK1;PDPK1;PI3K/AKT/mTOR;PRKACA, KDR, CDK2, CHEK1;NA;BX912;BX-912;;;Kinase inhibitor
190307;TG100-115;NA;PIK3CG, PIK3CD;PI3K;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190309;Ruxolitinib;INCB018424;JAK1, JAK2;JAK1/2;JAK/STAT;;Ruxolitinib;ruxolitinib;Ruxolitinib;;;Kinase inhibitor
190311;Bafilomycin A1;Bafilomycin, Baf-A1;ATP6V1A;vATPase;Autophagy;;NA;NA;NA;;;Other
190312;Staurosporine;NA;PRKCA, PRKCG, PRKCH;PKC;PKC;LCK, PIM1, ITK, SYK, MAPKAPK2, GSK3B, CSK, CDK2, PIK3CG, PDPK1, PRKCQ, ZAP70, CHRM1,PRKCD, PRKCE, FGR;NA;NA;NA;;;Kinase inhibitor
190313;Tipifarnib;R115777, Zarnestra;FNTA, FNTB;FTase;MAPK;;NA;tipifarnib;Tipifarnib;;;Differentiating /Epigenetic modifier
190314;VX-745;NA;MAPK14;p38;MAPK;;NA;NA;VX-745;;;Kinase inhibitor
190315;SP600125;NA;MAPK8, MAPK9, MAPK10;JNK;MAPK;AURKA, NTRK1, FLT3, MAP2K4, MAP2K6, AKT1, MAPK14, PRKCA;NA;NA;NA;;;Kinase inhibitor
190316;AZD6482;KIN001-193;PIK3CB;PI3K;PI3K/AKT/mTOR;PIK3CA,PIK3CD;NA;NA;NA;;;Kinase inhibitor
190318;Oligomycin A;NA;ATP5F1;Mitochondria;Metabolism;;NA;NA;Oligomycin A;;;Metabolic modifier
190319;Ponatinib;AP24534;ABL1, PDGFRA, KDR, FGFR1, SRC;ABL1;ABL (BCR);BCR, RET, TEK, FLT3, FGFR2, FGFR3, FGFR4. LCK, LYN,KIT;NA;NA;NA;;;Kinase inhibitor
190320;LY2228820;ralimetinib;p38 MAPK;p38;MAPK;MAPK14;NA;ralimetinib;NA;;;Kinase inhibitor
190321;Pralatrexate;Folotyn;DHFR;DHFR;Chemotherapy;TYMS;NA;NA;NA;;;Conventional Chemo
190322;AT7519;NA;CDK1, CDK2, CDK4, CDK6, CDK9;CDK;Cell cycle;GSK3B;NA;NA;NA;;;Kinase inhibitor
190323;MK-1775;NA;WEE1;WEE1;Cell cycle;;NA;MK-1775;NA;;;Kinase inhibitor
190324;Quizartinib;AC220;FLT3;FLT3;FLT3;;Quizartinib;NA;Quizartinib;;;Kinase inhibitor
190325;BIX-02188;BIX 02188, BIX02188;MAP2K5;MEK5;MAPK;MAPK7;NA;BIX02188;NA;;;Kinase inhibitor
190328;AZD8055;AZD8055;MTOR;MTOR;PI3K/AKT/mTOR;;AZD8055;NA;AZD8055;;;Kinase inhibitor
190329;BMS-777607;BMS777607;MET, AXL, MST1R, TYRO3;MET;HGF;;NA;NA;NA;;;Kinase inhibitor
190330;Pomalidomide;NA;TNF;TNF;TNF/NFKB;CRBN, PTGS2;NA;NA;NA;;;Immunomodulatory
190331;PD318088;NA;MAP2K1, MAP2K2;MEK1/2;MAPK;;NA;NA;NA;;;Kinase inhibitor
190332;KU-60019;NA;ATM;ATM;DDR;;NA;KU-60019;KU-60019;;;Kinase inhibitor
190333;BS-181;BS-181 HCL;CDK7;CDK7;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190334;RO4929097;NA;BACE1;BACE1;Notch;NOCTH1, NOTCH2, NOTCH3;NA;NA;NA;;;Other
190335;Semagacestat;LY450139;APP;APP;Notch;NOTCH1, NOTCH2, NOTCH3;NA;NA;Semagacestat;;;Other
190337;Orlistat;Tetrahydrolipstatin, Alli, Xenical;PNLIP, LIPF, FASN;Lipase;Metabolism;;NA;orlistat;Orlistat;;;Metabolic modifier
190338;Gemcitabine;Gemzar, LY-188011;RRM1, TYMS, CMPK1, CDA, DCK;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
190340;Bexarotene;Targretin, LG-100069, LGD-1069;RXRA, RXRB, RXRG;RXR;Vitamin;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190341;Neratinib;HKI-272;ERBB2, EGFR;EGFR;EGFR;KDR, SRC;NA;NA;NA;;;Kinase inhibitor
190342;Erismodegib;LDE225, NVP-LDE225;SMO;SMO;Hedgehog;;NA;NA;NA;;;Hedgehog inhibitor
190343;KW 2449;NA;FLT3;FLT3;FLT3;FGFR1, BCR/ABL, AURKA, PDGFRB, IGF1R, EGFR;NA;NA;NA;;;Kinase inhibitor
190344;RAF265;CHRI-265;BRAF, RAF1,BRAF(V600E);BRAF;MAPK;KDR;NA;NA;NA;;;Kinase inhibitor
190345;AZD1480;NA;JAK1, JAK2;JAK1/2;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190348;MLN9708;NA;PSMB5;Proteasome;Proteasome;;NA;NA;NA;;;Protease/Proteosome inhibitor
190350;GSK461364;NA;PLK1;PLK1;PLK;;NA;NA;NA;;;Kinase inhibitor
190351;R406;Tamatinib;SYK;SYK;BCR;FLT3;NA;tamatinib;R406;;;Kinase inhibitor
190352;SGI-1776;NA;PIM1;PIM1;JAK/STAT;PIM3, PIM2, FLT3;NA;SGI-1776;NA;;;Kinase inhibitor
190353;Torkinib;PP-242, PP242;MTOR;MTOR;PI3K/AKT/mTOR;PIK3CD, PRKDC, PDGFRA;NA;NA;NA;;;Kinase inhibitor
190354;Idelalisib;CAL-101, GS-1101;PIK3CD;PI3K;PI3K/AKT/mTOR;PIK3CG;Idelalisib;idelalisib;NA;;;Kinase inhibitor
190355;Galunisertib;LY2157299;TGFBR1;TGFBR1;TGF;;NA;NA;NA;;;Kinase inhibitor
190356;BI6727;BI 6727, Volasertib;PLK1;PLK1;PLK;PLK2,PLK3;Volasertib;NA;Volasertib;;Volasertib;Kinase inhibitor
190357;Silmitasertib;CX-4945;CSNK2A1;CK2;Wnt;FLT3, PIM1,CDK1;NA;silmitasertib;cx-4945;;;Kinase inhibitor
190358;Apocynin;Acetovanillone;NOX1;NOX;Metabolism;;NA;NA;NA;;;Metabolic modifier
190360;Rabusertib;IC-83, LY2603618;CHEK2;CHEK2;DDR;;NA;rabusertib;NA;;;Kinase inhibitor
190361;NU7441;NU-7432, KU-57788;PRKDC;PRKDC;DDR;PIK3CA;NA;NU7441;NU7441;;;Kinase inhibitor
190362;Omipalisib;GSK2126458, GSK458;PIK3CA, PIK3CD, PIK3CG, PIK3CB, MTOR;PI3K/MTOR;PI3K/AKT/mTOR;;NA;NA;Omipalisib;;;Kinase inhibitor
190363;ICG-001;ICG 001;CREBBP;CREBBP;Wnt;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190364;A-674563;NA;AKT1;AKT1;PI3K/AKT/mTOR;;A-674563;NA;NA;;;Kinase inhibitor
190365;AS-252424;AS 252424;PIK3CG;PI3K;PI3K/AKT/mTOR;CSNK2A1, PI3KCA;NA;NA;NA;;;Kinase inhibitor
190366;Trametinib;GSK1120212;MAP2K1, MAP2K2;MEK1/2;MAPK;;Trametinib;NA;Trametinib;;;Kinase inhibitor
190367;NSC-207895;XI-006;MDM4;MDM4;DDR;MDM2;NA;NA;NA;;;Apoptotic modulator
190368;Ibrutinib;PCI-32765;BTK;BTK;BCR;BLK, BMX, CSK, FGR, PTK6, HCK, EGFR, YES1;Ibrutinib;ibrutinib;Ibrutinib;;;Kinase inhibitor
190369;R547;NA;CDK1, CDK2, CDK4;CDK;Cell cycle;CDK7, GSK3A, GSK3B;NA;NA;NA;;;Kinase inhibitor
190370;TG101209;TG101209;JAK2;JAK2;JAK/STAT;FLT3, RET;NA;NA;NA;;;Kinase inhibitor
190371;Resminostat;RAS2410;HDAC1, HDAC3, HDAC6;HDAC1/3/6;Histone deacetylase;HDAC8;NA;NA;NA;;;Differentiating /Epigenetic modifier
190372;KX2-391;NA;SRC;SRC;BCR;;NA;KX2-391;KX2-391;;;Kinase inhibitor
190373;GSK1838705A;NA;IGF1R, INSR, ALK;IGF1R;IGF;ALK;NA;NA;NA;;;Kinase inhibitor
190374;ZM 336372;NA;RAF1;RAF1;MAPK;;ZM 336372;NA;NA;;;Kinase inhibitor
190375;MK-8776;SCH 900776;CHEK1;CHEK1;DDR;CDK2;NA;SCH 900776;MK-8776;;;Kinase inhibitor
190376;Fedratinib;TG-101348, SAR302503;JAK2;JAK2;JAK/STAT;FLT3, RET;NA;NA;NA;;;Kinase inhibitor
190377;PKI-402;NA;PIK3CA, PIK3CB, PIK3CD, PIK3CG, MTOR;PI3K/MTOR;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190378;CHIR-98014;Axon1126;GSK3A, GSK3B;GSK3A/B;GSK3;;NA;NA;NA;;;Kinase inhibitor
190379;Alectinib;CH5424802, 1256580-46-7;ALK;ALK;ALK;;NA;NA;NA;;;Kinase inhibitor
190380;Dinaciclib;SCH727965;CDK2, CDK5, CDK1 , CDK9;CDK;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190381;NSC 652287;RITA;MDM2, DNA;MDM2;DDR;;NA;NA;NA;;;Apoptotic modulator
190382;Tofacitinib;CP-690550, Tasocitinib;JAK1, JAK3;JAK1/3;JAK/STAT;JAK1, JAK2,JAK2;Tofacitinib;tofacitinib;NA;;;Kinase inhibitor
190383;Sotrastaurin;AEB071;PRKCQ, PRKCB, PRKCA, PRKCH,PRKCD, PRKCE;PKC;PKC;;NA;sotrastaurin;NA;;;Kinase inhibitor
190384;Dabrafenib;GSK2118436;BRAF(V600E), BRAF;BRAF;MAPK;SIK1, NEK11, LIMK1, RAF1;Dabrafenib;NA;NA;;;Kinase inhibitor
190385;Ipatasertib;GDC-0068;AKT1, AKT2, AKT3;AKT;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190386;Tideglusib;NA;GSK3B;GSK3B;GSK3;;NA;NA;NA;;;Kinase inhibitor
190387;R428;R-428, BGB324;AXL;AXL;TAM;;NA;NA;NA;;;Kinase inhibitor
190389;IKK-16;IKK Inhibitor VII;IKBKA, IKBKB;IKK;TNF/NFKB;;NA;NA;IKK-16;;;Kinase inhibitor
190390;PF-562271;KIN001-205;PTK2;PTK2;Cell adhesion;PTK2B, CDK1, CDK2, CDK3;NA;NA;NA;;;Kinase inhibitor
190393;WZ811;NA;CXCR4;CXCR4;Chemokine receptor;;NA;NA;NA;;;Other
190394;Salubrinal;NA;EIF2S1;EIF2S1;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190398;Mupirocin;NA;IARS;IARS;RNA synthesis;;NA;NA;NA;;;Other
190400;EVP4593;QNZ, 545380-34-5;TNF, NFKB1, NFKB2;TNF;TNF/NFKB;;NA;NA;NA;;;Other
190401;Fingolimod;FTY720;S1PR5;S1PR5;S1P;HDAC1;NA;NA;NA;;;Other
190402;GDC-0152;NA;XIAP, BIRC3, BIRC2;IAP;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190403;Birinapant;TL32711;BIRC2;IAP;Apoptosis;XIAP;NA;NA;NA;;;Apoptotic modulator
190404;Embelin;NA;XIAP;IAP;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190405;Duvelisib;IPI-145, INK1197;PI3KCD, PIK3CG;PI3K;PI3K/AKT/mTOR;PIK3CB;Duvelisib;duvelisib;Duvelisib;;;Kinase inhibitor
190406;GSK2656157;NA;EIF2AK3;EIF2AK3;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190407;Wnt-C59;C59;PORCN;PORCN;Wnt;;NA;NA;NA;;;Other
190408;Talazoparib;BMN 673;PARP1, PARP2;PARP1/2;DDR;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190409;CGI1746;CGI 1746;BTK;BTK;BCR;;NA;NA;NA;;;Kinase inhibitor
190410;PP1;172889-26-8;LCK, FYN;LCK/FYN;BCR;;NA;NA;NA;;;Kinase inhibitor
190411;EPZ-5676;NA;DOT1L;DOT1L;Histone methyltransferase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190412;SGC 0946;NA;DOT1L;DOT1L;Histone methyltransferase;;SGC 0946;NA;NA;;;Differentiating /Epigenetic modifier
190413;RN486;NA;BTK;BTK;BCR;;NA;NA;NA;;;Kinase inhibitor
190414;Ceritinib;LDK378;ALK;ALK;ALK;INSR, IGF1R;Ceritinib;NA;NA;;;Kinase inhibitor
190415;UNC1215;NA;L3MBTL3;L3MBTL3;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190416;IPA-3;IPA-3;PAK1;PAK1;Cytoskeleton;;NA;NA;NA;;;Kinase inhibitor
190417;PF-3758309;PF 3758309;PAK1, PAK6, PAK5, PAK4;PAK;Cytoskeleton;PAK2, PAK3;PF-3758309;NA;NA;;;Kinase inhibitor
190418;SCH772984;NA;MAPK3, MAPK1;ERK1/2;MAPK;;SCH772984;NA;SCH772984;;;Kinase inhibitor
190419;GDC-0032;NA;PI3KCA, PI3KCG, PI3KCD;PI3K;PI3K/AKT/mTOR;;NA;NA;GDC-0032;;;Kinase inhibitor
190420;AZD1208;NA;PIM1, PIM2, PIM3;PIM1/2/3;JAK/STAT;;AZD1208;NA;NA;;;Kinase inhibitor
190421;Encorafenib;LGX818;BRAF;BRAF;MAPK;;NA;encorafenib;Encorafenib;;;Kinase inhibitor
190423;Zebularine;Zebularine;DMAP1;DMAP1;DNA methyltransferase;AICDA;NA;NA;NA;;;Differentiating /Epigenetic modifier
190424;EPZ-6438;E7438;EZH2;EZH2;Histone methyltransferase;;EPZ-6438;NA;NA;;;Differentiating /Epigenetic modifier
190425;LGK-974;LGK-974;PORCN;PORCN;Wnt;;NA;NA;NA;;;Other
190426;C646;NA;EP300;P300/CBP;Histone acetyltransferase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190427;Batimastat;BB-94;MMP1, MMP2, MMP3, MMP7, MMP9;MMP;MMP;MMP12, MMP8, MMP16, ADAM28, ADAMTS5;NA;NA;NA;;;Protease/Proteosome inhibitor
190428;Marimastat;BB-2516;MMP9, MMP2, MMP1, MMP14;MMP;MMP;MMP7, MMP3;NA;NA;NA;;;Protease/Proteosome inhibitor
190429;GM6001;Ilomastat, Galardin;MMP1, MMP2, MMP3, MMP7, MMP8, MMP9, MMP12, MMP14, MMP26;MMP;MMP;;NA;NA;NA;;;Protease/Proteosome inhibitor
190430;Motolimod;VTX-2337;TLR8;TLR8;TLR;TLR7;Motolimod;NA;NA;;;Immunomodulatory
190431;Spebrutinib;CC-292, AVL-292;BTK;BTK;BCR;;NA;spebrutinib;NA;;;Kinase inhibitor
190432;ABC294640;NA;SPHK2;SPHK2;S1P;;NA;NA;NA;;;Kinase inhibitor
190433;SKI II;Sphingosine Kinase Inhibitor 2;SPHK1, SPHK2;SPHK1/2;S1P;;NA;NA;NA;;;Kinase inhibitor
190434;Siponimod;BAF312;S1PR1, S1PR5;S1PR1/5;S1P;;NA;NA;NA;;;Other
190435;AGI-5198;NA;IDH1;IDH1;Metabolism;IDH1 R132H and R132C mutants;NA;NA;NA;;;Metabolic modifier
190436;I-BET-762;GSK525762A;BRD2, BRD3, BRD4;BET;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190437;RKI-1447;NA;ROCK1, ROCK2;ROCK;Cytoskeleton;;NA;NA;NA;;;Kinase inhibitor
190438;Ro 31-8220;NA;PRKCA, PRKCB, PRKCE, PRKCG;PKC;PKC;RPS6KA2, RPS6KA5, RPS6KB1, GSK3B;NA;NA;NA;;;Kinase inhibitor
190439;GSK650394;NA;SGK1, SGK2;SGK;SGK;;NA;NA;NA;;;Kinase inhibitor
190440;AGI-6780;NA;IDH2;IDH2;Metabolism;;NA;NA;NA;;;Metabolic modifier
190441;Selinexor;KPT-330;XPO1;XPO1;Nuclear export;;Selinexor;NA;Selinexor;;;Apoptotic modulator
190442;CNX-774;NA;BTK;BTK;BCR;;NA;NA;NA;;;Kinase inhibitor
190443;PD173955;NA;BCR/ABL;BCR/ABL;ABL (BCR);SRC;NA;NA;NA;;;Kinase inhibitor
190444;SRPIN340;NA;SRPK1, SRPK2;SRPK1/2;RNA splicing;;NA;NA;NA;;;Kinase inhibitor
190445;FRAX597;NA;PAK1, PAK2, PAK3;PAK;Cytoskeleton;;NA;NA;NA;;;Kinase inhibitor
190446;JIB04;NSC693627;KDM5A, KDM4D, KDM4E, KDM4B, KDM4A;JMJD;Histone demethylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190447;ML324;NA;KDM4A;JMJD;Histone demethylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190448;AZD9291;Osimertinib;EGFR;EGFR;EGFR;;NA;NA;NA;;;Kinase inhibitor
190449;MS436;NA;BRD4;BRD4;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190451;STF-118804;NA;NAMPT;NAMPT;Metabolism;;NA;NA;NA;;;Metabolic modifier
190452;EHop-016;NA;RAC1, RAC3;RAC;Cytoskeleton;;NA;NA;NA;;;Other
190453;TG003;TG003;CLK1, CLK2, CLK4;CLK;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190454;TMP269;NA;HDAC4, HDAC5, HDAC7, HDAC9;pan-HDAC;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190455;ERK5-IN-1;XMD17-109;MAPK7;ERK5;MAPK;;NA;NA;NA;;;Kinase inhibitor
190456;SH-4-54;NA;STAT3, STAT5;STAT3/5;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190457;AZ191;NA;DYRK1B;DYRK1B;Cell cycle;DYRK1A;NA;NA;NA;;;Kinase inhibitor
190458;BAY 11-7085;NA;NFKBIA;NFKB;TNF/NFKB;;NA;BAY 11-7085;NA;;;Kinase inhibitor
190459;OTX015;NA;BRD2, BRD3, BRD4;BET;Bromodomain;;OTX015;NA;OTX015;;;Differentiating /Epigenetic modifier
190460;UNC669;NA;L3MBTL1;L3MBTL1;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190461;Calpeptin;NA;CAPN1;CAPN1;Cystein protease;;NA;NA;NA;;;Protease/Proteosome inhibitor
190463;ISRIB (trans-isomer);ISRIB (trans-isomer);EIF2AK3;EIF2AK3;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190464;KN-62;NA;CAMK2A, CAMK2B;CAMK2;Calcium signaling;;NA;NA;NA;;;Kinase inhibitor
190465;KN-93 Phosphate;KN-93;CAMK2A, CAMK2B;CAMK2;Calcium signaling;;NA;NA;NA;;;Kinase inhibitor
190467;NH125;EEF-2 Kinase Inhibitor;EEF2K;EEF2K;Protein synthesis;;NA;NA;NA;;;Kinase inhibitor
190468;Ribociclib;LEE011;CDK4, CDK6;CDK4/6;Cell cycle;;NA;NA;NA;;;Kinase inhibitor
190469;FTI 277 HCl;NA;FNTA, FNTB;FTase;MAPK;;NA;NA;NA;;;Kinase inhibitor
190469;FTI-277 TRIFLUOROACETATE SALT;NA;FNTA, FNTB;FTase;MAPK;;NA;NA;NA;;;Kinase inhibitor
190470;LB42708;NA;FNTA, FNTB;FTase;MAPK;HRAS, NRAS, KRAS;NA;NA;LB42708;;;Kinase inhibitor
190471;Nexturastat A;NA;HDAC6;HDAC6;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190472;EHT 1864;NA;RAC1, RAC2;RAC;Cytoskeleton;RAC3;NA;NA;EHT 1864;;;Other
190473;CCT007093;NA;PPM1D;PPM1D;Stress response;;NA;NA;NA;;;Phosphatase inhibitor
190474;WIKI4;WIKI4;TNKS2;TNKS2;Wnt;;NA;NA;NA;;;Other
190475;GNF-5837;NA;NTRK1, NTRK2, NTRK3;NTRK1/2/3;Trk;;NA;NA;NA;;;Kinase inhibitor
190476;Afuresertib;GSK2110183;AKT1, AKT2, AKT3;AKT;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190477;Entospletinib;GS-9973;SYK;SYK;BCR;;NA;NA;NA;;;Kinase inhibitor
190478;XMD8-92;XMD8-92;MAPK7;ERK5;MAPK;MAPK7;NA;NA;NA;;;Kinase inhibitor
190479;EW-7197;NA;TGFBR1;TGFBR1;TGF;;NA;NA;NA;;;Kinase inhibitor
190480;UMI-77;NA;MCL1;MCL1;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190481;WH-4-023;KIN001-112;SRC, LCK;LCK/SRC;BCR;SIK;NA;NA;NA;;;Kinase inhibitor
190482;LMK-235;NA;HDAC4, HDAC5;HDAC4/5;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190483;GSK2830371;NA;PPM1D;PPM1D;Stress response;;NA;NA;GSK2830371;;;Phosphatase inhibitor
190484;GSK-LSD1 2HCl;NA;KDM1A;LSD1;Histone demethylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190485;CAY10603;NA;HDAC6;HDAC6;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190486;Filgotinib;GLPG0634;JAK1;JAK1;JAK/STAT;JAK2, TYK2;NA;NA;NA;;;Kinase inhibitor
190487;CPI-169;CPI-169;EZH2;EZH2;Histone methyltransferase;EZH1;NA;NA;NA;;;Differentiating /Epigenetic modifier
190488;MI-2 (Menin-MLL inhibitor);MI-2;MEN1;MEN1;Histone methyltransferase;;Menin-MLL Inhibitor;NA;NA;;;Differentiating /Epigenetic modifier
190489;I-BET726;GSK1324726A;BRD2, BRD3, BRD4;BET;Bromodomain;BRD3, BRD2;NA;NA;NA;;;Differentiating /Epigenetic modifier
190490;LDC1267;NA;MER, TYRO3, AXL;TAM;TAM;;NA;NA;NA;;;Kinase inhibitor
190491;D-4476;D 4476;CSNK1A1;CK1;Wnt;ALK5;D4476;NA;D 4476;;;Kinase inhibitor
190492;MI-773;SAR405838;MDM2;MDM2;DDR;;NA;NA;NA;;;Apoptotic modulator
190493;Peficitinib;ASP015K, JNJ-54781532;JAK1, JAK2, JAK3;JAK1/2/3;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190494;SB225002;SB 225002;CXCR2;CXCR2;Chemokine receptor;;NA;NA;NA;;;Other
190495;SP2509;NA;LSD1;LSD1;Histone demethylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190496;OF-1;NA;BRPF1, BRD1;BET;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190497;AZD6738;NA;ATR;ATR;DDR;;AZD6738;NA;NA;;;Kinase inhibitor
190498;LY2409881;946518-60-1;IKBKB;IKK;TNF/NFKB;;NA;NA;NA;;;Kinase inhibitor
190499;LY2584702;NA;RPS6KB1;RPS6KB1;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190500;Verdinexor;KPT-335;XPO1;XPO1;Nuclear export;;NA;NA;NA;;;Apoptotic modulator
190501;BLZ945;BLZ-945;CSF1R;CSF1R;Chemokine receptor;;NA;NA;NA;;;Other
190502;BRD73954;NA;HDAC6, HDAC8;HDAC6/8;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190503;VER155008;1134156-31-2;HSP70;HSP70;Stress response;HSC70, GRP78;NA;NA;NA;;;HSP inhibitor
190504;Dovitinib;TKI258, CHIR-258, Dovitinib Lactate;FLT3, KIT, FGFR1, FLT4, FGFR3;FLT3;FLT3;FLT1, KDR, PDGFRB;NA;NA;NA;;;Kinase inhibitor
190507;A-1210477;NA;MCL1;MCL1;Apoptosis;;A-1210477;NA;A-1210477;;;Apoptotic modulator
190508;Dorsomorphin;Compound C;PRKAA1;AMPK;Metabolism;;NA;NA;NA;;;Metabolic modifier
190509;SirReal2;SirReal 2;SIRT2;SIRT2;DDR;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190510;TP-0903;CHEMBL2022968;AXL;AXL;TAM;;NA;NA;NA;;;Kinase inhibitor
190511;ONO-4059;NA;BTK;BTK;BCR;;ONO-4059;NA;NA;;;Kinase inhibitor
190512;AMI-1;PRMT Inhibitor;PRMT1;PRMT1;Histone methyltransferase;;AMI-1;NA;NA;;;Differentiating /Epigenetic modifier
190513;Napabucasin;UNII-Z1HHM49K7O;STAT3;STAT3;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190514;SMI-4a;NA;PIM1;PIM1;JAK/STAT;PIM2;NA;NA;NA;;;Kinase inhibitor
190515;BIX-01294;BIX 01294, BIX01294;EHMT2;G9A;Histone methyltransferase;EHMT1;NA;NA;NA;;;Differentiating /Epigenetic modifier
190516;VE-821;NA;ATR;ATR;DDR;;NA;VE-821;NA;;;Kinase inhibitor
190517;Plerixafor;AMD3100;CXCR4, CXCL12;CXCR4;Chemokine receptor;;NA;NA;NA;;;Other
190518;PRT062607;P505-15, BIIB057, PRT062607 HCL;SYK;SYK;BCR;FGR, MAP3K9;PRT062607;PRT062607 HCl;PRT062607;;;Kinase inhibitor
190520;Cobimetinib;GDC-0973, XL-518, Cotellic, RG7420;MAP2K1;MEK1;MAPK;;Cobimetinib;NA;Cobimetinib;;;Kinase inhibitor
190522;KU-0060648;NA;PI3KCA, PI3KCB, PI3KCD, PRKDC;PI3K;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190523;Venetoclax;Abt-199, GDC-0199;BCL2;BCL2;Apoptosis;;Venetoclax;venetoclax;Venetoclax;;;Apoptotic modulator
190524;Nutlin-3a;Nutlin-3a (-) enantiomer, nutlin-3;MDM2;MDM2;DDR;;Nutlin-3a;nutlin-3;Nutlin-3a;;;Apoptotic modulator
190525;Sabutoclax;BI-97C1;MCL1, BCL2L1, BCL2, BCL2A1;BCL2;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190526;GANT61;NA;GLI1;GLI1;Hedgehog;;NA;NA;NA;;;Hedgehog inhibitor
190527;GMX1778;CHS828;NAMPT;NAMPT;Metabolism;;NA;NA;GMX1778;;;Metabolic modifier
190530;CCT251545;CCT-251545;CDK8, CDK19;CDK8/19;Wnt;;NA;NA;NA;;;Kinase inhibitor
190531;MI-503;MI-2-2;MEN1;MEN1;Histone methyltransferase;;MI-503;NA;NA;;;Differentiating /Epigenetic modifier
190532;Lestaurtinib;CEP-701;FLT3, JAK2, NTRK1;FLT3;FLT3;AURKA, AURKB;NA;NA;NA;;;Kinase inhibitor
190535;VU 0155069;VU0155069, 1130067-06-9;PLD1;PLD1;Phospholipase;PLD2;NA;NA;NA;;;Other
190536;CTA056;CTA056;ITK;ITK;ITK;;NA;NA;NA;;;Kinase inhibitor
190538;CU-CPT22;CU CPT 22;TLR1, TLR2;TLR1/2;TLR;;NA;NA;NA;;;Immunomodulatory
190539;MM-102;MM102;WDR5;WDR5;Histone methyltransferase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190540;SANT-2;NA;SMO;SMO;Hedgehog;;NA;NA;NA;;;Hedgehog inhibitor
190541;TCS PIM-1 1;NA;PIM1;PIM1;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
190542;NSC-87877;NA;PTPN6, PTPN11;SHP;SHP;;NA;NA;NA;;;Phosphatase inhibitor
190543;JW55;JW 55;TNKS, TNKS2;TNKS;Wnt;;NA;NA;NA;;;Other
190544;VO-Ohpic;NA;PTEN;PTEN;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190545;Swainsonine;NA;MAN2A1;MAN2A1;Protein processing;;NA;NA;NA;;;Immunomodulatory
190547;BAG 956;BAG956;PDPK1, PIK3CA, PIK3CB, PIK3D, PIK3CG;PDPK1;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
190550;BML-277;Chk2 Inhibitor II;CHEK2;CHEK2;DDR;;BML-277;BML-277;NA;;;Kinase inhibitor
190551;JNJ-28312141;NA;CSF1R, FLT3;CSF1R;Chemokine receptor;;NA;NA;NA;;;Kinase inhibitor
190552;Piericidin A;Piericidin A;NDUFS4;NDUFS4;Metabolism;;NA;NA;Piericidin A;;;Metabolic modifier
190553;Ruboxistaurin;LY-333531;PRKCB;PRKCB;PKC;;NA;NA;NA;;;Kinase inhibitor
190554;Thapsigargin;NA;ATP2A1, ATP2A2;ATP2A;Calcium signaling;;NA;thapsigargin;NA;;;Phosphatase inhibitor
190555;P-M2tide;NA;PKM;PKM;Metabolism;;NA;NA;NA;;;Metabolic modifier
190556;MIS-27.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190557;MIS43.1;MIS-43;ROS;ROS;ROS;;NA;MIS-43;NA;;;ROS
190558;SD07.1;SD07;ROS;ROS;ROS;;NA;SD07;NA;;;ROS
190559;SD40.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190560;SD50.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190561;SD52.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190562;WH17.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190563;OV21.1;NA;ROS;ROS;ROS;;NA;NA;NA;;;ROS
190564;z-LVSR-fmk MALT1;NA;MALT1;MALT1;TNF/NFKB;;NA;NA;NA;;;Protease/Proteosome inhibitor
190570;Sodium dichloroacetate;NA;PDK1;PDK1;Metabolism;GSTZ1;NA;NA;NA;;;Metabolic modifier
190572;Actinonin;NA;PDF, ANPEP;Aminopeptidase;Metabolism;;NA;NA;NA;;;Metabolic modifier
190573;Acadesine;AICAR, N1-(b-D-Ribofuranosyl)-5-aminoimidazole-4-carboxamide;PRKAA1;AMPK activator;Metabolism;;NA;NA;NA;;;Metabolic modifier
190574;Brefeldin A;B7651, Cyanein, Decumbin;ARF1;ARF1;Protein transport;CYTH2;NA;NA;NA;;;Other
190575;BAY 61-3606;Syk Inhibitor IV;SYK;SYK;BCR;CDK9;NA;NA;BAY61-3606;;;Kinase inhibitor
190576;BMS-345541;BMS345541;IKBKA, IKBKB;IKK;TNF/NFKB;;NA;NA;BMS-345541;;;Kinase inhibitor
190577;Cytarabine;Ara-Cytidine, Arabinosyl Cytosine, U-19920, AraC, Cytosine b-D-arabinofuranoside;DNA;DNA;Chemotherapy;POLB;Cytarabine;NA;NA;;;Conventional Chemo
190578;LAPATINIB;NA;EGFR, ERBB2;EGFR;EGFR;EGFR, ERBB2;NA;NA;NA;;;Kinase inhibitor
190579;Nilotinib;AMN-107;BCR/ABL;BCR/ABL;ABL (BCR);KIT;NA;NA;NA;;;Kinase inhibitor
190580;PAZOPANIB;NA;FLT1, KDR, FLT4;VEGFR;Angiogenesis;PDGFRA, PDGFRB, KIT, ITK, FGF1, SH2B3;NA;NA;NA;;;Kinase inhibitor
190581;Diphenyleneiodonium chloride;Diphenyleneiodonium;NOS1, NOS2, NOS3, NOX3, NOX1;NOS/NOX;Metabolism;;NA;NA;NA;;;Metabolic modifier
190583;10058-F4;C-Myc Inhibitor;MYC;MYC;Cell cycle;HSP90;10058-F4;NA;10058-F4;;;Other
190586;HPI-1 Hydrate;Hh Signaling Antagonist XII, ST093553;GLI1, GL12;GLI1/2;Hedgehog;;NA;NA;NA;;;Hedgehog inhibitor
190587;IRAK-1/4 INHIBITOR I;NA;IRAK1, IRAK4;IRAK1/4;TLR;;IRAK1/4 Inhibitor I;NA;NA;;;Kinase inhibitor
190588;PKF118;PKF118-310;CTNNB1;CTNNB1;Wnt;;NA;NA;NA;;;Other
190589;LFM-A13;DDE-28;BTK;BTK;BCR;;NA;NA;NA;;;Kinase inhibitor
190590;Mitomycin C;Mytozytrex,NSC-26980;DNA;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
190591;Midostaurin hydrate;PKC 412, PKC-412;PRKCA, PRKCG, PRKCB, KDR, SYK;PKC;PKC;PRKCH, PRKCD, KDR, CDK1, PRKACA, FGR, SRC, FLT1, EGFR, PRKCE;Midostaurin;NA;NA;;;Kinase inhibitor
190592;JTE-013;JTE 013;S1PR2;S1PR2;S1P;;NA;NA;NA;;;Other
190593;PYR-41;PYR-41;UBA1;UBA1;Ubiquitinylation;;NA;NA;PYR-41;;;Differentiating /Epigenetic modifier
190594;PAC-1;PAC-1;CASP3;CASP3;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
190595;Prednisolone;NA;NR3C1;Corticosteroid;Corticosteroid;;NA;NA;NA;;;Immunomodulatory
190599;SJ-172550;SJ 172550;MDM4;MDM4;DDR;;NA;NA;NA;;;Apoptotic modulator
190600;NSC-109555;DDUG diMS, NSC 109555;CHEK2;CHEK2;DDR;;NA;NA;NA;;;Kinase inhibitor
190601;ICRT14;NA;CTNNB1;CTNNB1;Wnt;;NA;NA;NA;;;Other
190602;Pentostatin;deoxycoformycin, Nipent;ADA;ADA;Purine metabolism;;NA;NA;NA;;;Conventional Chemo
190603;Ro-3306;NA;CDK1;CDK1;Cell cycle;PRKCD, SGK1;NA;NA;NA;;;Kinase inhibitor
190604;GSK2801;NA;BAZ2A, BAZ2B;BAZ2;Bromodomain;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190605;OICR-9429;NA;WDR5;WDR5;Histone methyltransferase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
190606;JNK-IN-8;GTPL8058;MAPK8, MAPK9, MAPK10;JNK;MAPK;KIT;JNK-IN-8;NA;JNK-IN-8;;;Kinase inhibitor
190607;VAS2870;NOX Inhibitor III;NOX1;NOX1;Metabolism;;NA;NA;NA;;;Metabolic modifier
190608;UNC0638;NA;EHMT1, EHMT2;G9A/GLP;Histone methyltransferase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
200367;Selisistat;EX-527, EX527;SIRT1;SIRT1;DDR;;Selisistat;NA;NA;;;Differentiating /Epigenetic modifier
251000;Dasatinib;BMS-354825;ABL1, SRC, KIT;ABL1;ABL (BCR);EPHA2,LCK,YES1,PDGFRB,STAT5B, ABL2,FYN, BTK,NR4A3,BCR, CSK, EPHA5,EPHB4, FGR,FRK,HSPA8,LYN,ZAK, MAPK14, PPAT;Dasatinib;dasatinib;Dasatinib;;;Kinase inhibitor
251001;Erlotinib;NA;EGFR;EGFR;EGFR;NR1, NR2;NA;NA;NA;;;Kinase inhibitor
251002;Gefitinib;ZD-1839, Iressa;EGFR;EGFR;EGFR;;NA;gefitinib;Gefitinib;;;Kinase inhibitor
251004;Panobinostat;LBH589, Faridak;HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, HDAC10, HDAC11;pan-HDAC;Histone deacetylase;;Panobinostat;NA;NA;;;Differentiating /Epigenetic modifier
251005;Everolimus;RAD001;MTOR;MTOR;PI3K/AKT/mTOR;;NA;everolimus;Everolimus;;;Rapalog
251006;Vemurafenib;PLX-4032;BRAF(V600E);BRAF(V600E);MAPK;BRAF, RAF1;NA;NA;NA;;;Kinase inhibitor
251008;Entinostat;MS-275, SNDX-275;HDAC1, HDAC3;HDAC1/3;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
251009;Belinostat;PXD101;HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9, HDAC10, HDAC11;pan-HDAC;Histone deacetylase;;NA;NA;NA;;;Differentiating /Epigenetic modifier
251017;Ixazomib;MLN2238;Proteasome;Proteasome;Proteasome;;NA;NA;NA;;;Protease/Proteosome inhibitor
251020;Carfilzomib;PR-171;PSMB5;Proteasome;Proteasome;;NA;NA;NA;;;Protease/Proteosome inhibitor
251021;Romidepsin;FK228, Depsipeptide;HDAC1, HDAC2;HDAC1/2;Histone deacetylase;HDAC4, HDAC6, ABCC1;NA;NA;NA;;;Differentiating /Epigenetic modifier
251028;JQ1;(+)-JQ1, JQ-1;BRD2, BRD3, BRD4, BRDT;BET;Bromodomain;CREBBP;NA;NA;NA;;;Differentiating /Epigenetic modifier
252003;Crizotinib;PF-02341066;MET, ALK;MET;HGF;;NA;NA;NA;;;Kinase inhibitor
252006;BGJ398;NVP-BGJ398;FGFR1, FGFR2, FGFR3;FGFR;FGFR;FGFR4;BGJ398;NA;NA;;;Kinase inhibitor
252007;Vismodegib;GDC-0449;SMO;SMO;Hedgehog;P-gp;Vismodegib;NA;Vismodegib;;;Hedgehog inhibitor
420298;Methotrexate;Abitrexate;DHFR;DHFR;Chemotherapy;;Methotrexate;NA;NA;;;Conventional Chemo
420375;Thalidomide;NA;TNF;TNF;TNF/NFKB;CRBN, NFKB1, DNA, FGFR2, PTGS2;NA;NA;NA;;;Differentiating /Epigenetic modifier
420448;Mitoxantrone;Mitoxantrone dihydrochloride;TOP2A, DNA;DNA;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
420489;Resveratrol;NA;SIRT1, SIRT2, PTGS1, PTGS2, ALOX15, ALOX5;SIRT/PTGS/LOX;Promiscuous;NQO2, CSNK2A1, AHR, PI4K2B, ITGA5, ITGB3, APP, SNCA, ESR1, MTNR1A, MTNR1B, CLEC14A, NR1I2, NR1I3, SLC2A1, CBR1, PPARA, PPARG, AKT1, KHSRP, YARS,IKBKB, POLA1, LOX;NA;NA;NA;;;Differentiating /Epigenetic modifier
420710;Nifuroxazide;NA;STAT1, STAT3, STAT5;STAT1/3/5;JAK/STAT;;NA;NA;NA;;;Kinase inhibitor
420846;Ebselen;NA;EPHX2;EPHX2;Metabolism;;NA;NA;NA;;;Metabolic modifier
420903;Thiostrepton;NA;FOXM1;FOXM1;Cell cycle;;NA;NA;NA;;;Other
440075;Dexamethasone;NA;NR3C1;Corticosteroid;Corticosteroid;NR3C1, NR0B1, ANXA1, NOS2, NR1I2;NA;NA;NA;;;Immunomodulatory
440169;Irinotecan;CamptosarÊ;TOP1;TOP1;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
440184;Rizatriptan;Maxalt;HTR1B, HTR1D;HTR1B/D;Serotonin;HTR1F;NA;NA;NA;;;Other
440191;Imatinib;Gleevec, STI-571, STI571;BCR/ABL, ABL1, KIT, PDGFRA, PDGFRB;BCR/ABL;ABL (BCR);RET, NTRK1, CSF1R, DDR1, CYP3A4, CYP3A5, CYP3A7, CYP1A2, CYP2C9, CYP2D6, CYP2C19, PTGS1, ALB, ORM1,     ABCB1, SLC22A1;Imatinib;NA;NA;;;Kinase inhibitor
440336;Vinorelbine;NA;TUBB;TUBB;Chemotherapy;;NA;NA;NA;;;Conventional Chemo
440361;Dactinomycin;Actinomycin D;DNA, TOP2A;DNA;Chemotherapy;;NA;actinomycin D;NA;;;Conventional Chemo
440542;5-Nonyloxytryptamine;5-Nonyloxytryptamine oxalateÊ;HTR1B;HTR1B;Serotonin;;NA;NA;NA;;;Other
450031;GSK269962;KIN001-155, GSK 269962A;ROCK1, ROCK2;ROCK;Cytoskeleton;;NA;NA;NA;;;Kinase inhibitor
450151;GW2580;NA;CSF1R;CSF1R;Chemokine receptor;;NA;NA;NA;;;Other
450240;GW843682X;KIN001-134, 660868-91-7;PLK1, PLK3;PLK1/3;PLK;;NA;NA;NA;;;Kinase inhibitor
450429;GW441756;GW 441756;NTRK1;NTRK1;Trk;;NA;NA;NA;;;Kinase inhibitor
451188;GSK2606414;NA;EIF2AK3;EIF2AK3;Apoptosis;;NA;NA;NA;;;Apoptotic modulator
451198;ZM 447439;ZM447439;AURKA, AURKB;AURKA/B;Cell cycle;LCK, SRC, MAP2K1;NA;NA;NA;;;Kinase inhibitor
451215;GSK429286A;NA;ROCK1, ROCK2;ROCK;Cytoskeleton;;NA;NA;GSK429286A;;;Kinase inhibitor
451344;Canertinib;CI-1033;EGFR, ERBB2;EGFR;EGFR;;NA;NA;NA;;;Kinase inhibitor
451374;Doramapimod;BIRB 0796, BIRB 796, p38 MAP Kinase Inhibitor X, JNK Inhibitor XVII;MAPK14, MAPK11;p38;MAPK;RAF1, FYN, LCK;NA;NA;NA;;;Kinase inhibitor
470019;PD184352;CI-1040;MAP2K1, MAP2K2;MEK1/2;MAPK;MEK5;NA;NA;NA;;;Kinase inhibitor
470038;PF-573228;PF 573228;PTK2;PTK2;Cell adhesion;;NA;NA;NA;;;Kinase inhibitor
470044;PF-477736;PF 477736;CHEK1;CHEK1;DDR;KDR, CSF1R, YES1, CHEK2, FGFR3, AURKA;NA;PF 477736;PF 477736;;;Kinase inhibitor
470069;PD407824;PD-407824;WEE1, CHEK1;CHEK1;DDR;;NA;NA;NA;;;Kinase inhibitor
470072;PHA-767491;PHA767491, PHA 767491;CDK9, CDC7;CDC7/CDK9;Cell cycle;GSK3B, CDK1, CDK2;NA;NA;NA;;;Kinase inhibitor
470073;Bosutinib;SKI-606;ABL1, SRC;ABL1;ABL (BCR);LYN, HCK, CDK2,MAP2K2, MAP2K;NA;NA;NA;;;Kinase inhibitor
470077;PF-4708671;PF 4708671;RPS6KB1;RPS6KB1;PI3K/AKT/mTOR;;NA;NA;NA;;;Kinase inhibitor
470079;Axitinib;AG-013736;VEGFR1, VEGFR2, VEGFR3, PDGFR, KIT;VEGFR;Angiogenesis;;NA;NA;NA;;;Kinase inhibitor
472567;Tandutinib;MLN-518, MLN518;FLT3;FLT3;FLT3;PDGFD,PDGFRB, KIT;NA;NA;NA;;;Kinase inhibitor
472677;Imiquimod;Aldara;TLR7;TLR7;TLR;TLR8;NA;NA;NA;;;Immunomodulatory
472920;Hydroxychloroquine Sulfate;NA;TLR9;TLR9;TLR;TLR7, DNA,Autophagy;NA;NA;NA;;;Immunomodulatory
474205;Rotenone;NA;NDUFS4;NDUFS4;Metabolism;TUBB;NA;rotenone;NA;;;Metabolic modifier
510179;Roscovitine;Seliciclib, CYC202;CDK1, CDK2, CDK5;CDK;Cell cycle;MAPK1;NA;NA;NA;;;Kinase inhibitor
510455;MLN8054;NA;AURKA;AURKA;Cell cycle;AURKB;NA;NA;NA;;;Kinase inhibitor
510541;Bortezomib;LDP-341,PS-341, Velcade;PSMB5;Proteasome;Proteasome;;NA;bortezomib;NA;;;Protease/Proteosome inhibitor
510719;Sorafenib;BAY-43-9006,Nexavar;RAF1, BRAF, KDR;RAF1;MAPK;FLT4, FLT3, PDGFRB, KIT, RET, FLT1,FGFR1;NA;NA;NA;;;Kinase inhibitor
510720;Sunitinib;NA;KDR, PDGFRB, FLT3, KIT;RTK;VEGFR;FLT1, FLT4, CSF1R, PDGFRA;Sunitinib;sunitinib;NA;;;Kinase inhibitor
703625;Z29324237;NA;Unknown;Unknown;Unkown;;NA;NA;NA;;;Other
727944;MI-2 (MALT1 inhibitor);NA;MALT1;MALT1;TNF/NFKB;;NA;NA;NA;;;Protease/Proteosome inhibitor
744363;CGX-10717747;NA;Unknown;Unknown;Unkown;;NA;NA;NA;;;Other
CPS_05;RO5963;NA;MDM2, MDM4;MDM2/MDM4;DDR;;RO5963;NA;NA;;;Apoptotic modulator
CPS_10;Ganetespib;STA-9090;HSP90AA1, HSP90AB1;HSP90;Stress response;;Ganetespib;NA;NA;;;HSP inhibitor
IC50_034;Chaetocin;NA;HMT;pan-HMT;Histone methyltransferase;;NA;chaetocin;NA;;;Differentiating /Epigenetic modifier
IC50_060;Cephaeline;NA;RPS3, RPS19;Ribosome;Protein synthesis;;NA;cephaeline;NA;;;Other
IC50_066;Arsenic trioxide;NA;Unknown;Unknown;Unkown;;NA;arsenic trioxide;NA;;;Differentiating /Epigenetic modifier
IC50_141;SD51;NA;ROS;ROS;ROS;;NA;SD51;NA;;;ROS
IC50_163;CCT241533;NA;CHEK2;CHEK2;Cell cycle;;NA;CCT241533;NA;;;Kinase inhibitor
IC50_167;UCN-01;7-hydroxystaurosporine;PRKCA, PRKCB, PRKCE, PRKCG;PKC;PKC;;NA;UCN-01;NA;;;Kinase inhibitor
IC50_CHK;BML-277 + rabusertib;NA;CHEK1, CHEK2;CHEK1/2;Cell cycle;;NA;BML-277 + rabusertib;NA;;;Kinase inhibitor
SZ_1;SBI-0206965;;ULK1;ULK1;Autophagy;;NA;NA;;;SBI-0206965;Kinase inhibitor
SZ_2;SL0101;;RPS6KA1;RPS6KA1;MAPK;;NA;NA;;;SL0101;Kinase inhibitor
SZ_3;RK33;;DDX3;DDX3;Cell cycle;;;;;;RK33;Other
TP53_1;795;NA;CDC25;CDC25;Cell cycle;;NA;NA;;;;Phosphatase inhibitor
TP53_2;NSC 663284;NA;CDC25;CDC25;Cell cycle;;NA;NA;;;;Phosphatase inhibitor
TP53_3;140;NA;CDC25;CDC25;Cell cycle;;NA;NA;;;;Phosphatase inhibitor
TRI12_1;Compound 26;NA;IRAK4;IRAK4;TLR;;NA;NA;Compound 26;;;Kinase inhibitor
TRI12_2;MLN-120B;MLN120B;IKBKB;IKK;TNF/NFKB;;NA;NA;MLN-120B;;;Kinase inhibitor
TRI12_3;AS2444697;AS 2444696;IRAK4;IRAK4;TLR;;NA;NA;AS2444697;;;Kinase inhibitor
TRI12_4;Acalabrutinib;NA;BTK;BTK;BCR;;NA;NA;Acalabrutinib;;;Kinase inhibitor